- Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply CNBC
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Investors | Eli Lilly and Company
- Viking Therapeutics (VKTX) Fell Amid…
[ad_2]
Source link
